Phase I dose-finding study of golvatinib (E7050), a c-Met and Eph receptor targeted multi-kinase inhibitor, administered orally QD to patients with advanced solid tumors.

Gennaro Daniele, Malcolm Ranson, Montserrat Blanco-Codesido, Emma Jane Dean, Krunal Jitendrakumar Shah, Matthew Krebs, Andre Brunetto, Alastair Greystoke, Claire Johnston, Galina Kuznetsov, Mark Matijevic, Bipin Mistry, Begona de Las Heras, L Rhoda Molife

    Research output: Contribution to journal › Commentary/debate › peer-review

    Fingerprint

    Dive into the research topics of 'Phase I dose-finding study of golvatinib (E7050), a c-Met and Eph receptor targeted multi-kinase inhibitor, administered orally QD to patients with advanced solid tumors.'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science